ClinicalTrials.Veeva

Menu

Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections

H

Hadassah Medical Center

Status

Enrolling

Conditions

Urinary Tract Infections
Menopause

Study type

Observational

Funder types

Other

Identifiers

NCT04305808
0014-20-HMO

Details and patient eligibility

About

The objectives are to evaluate whether variations in vaginal and/or urinary and/or fecal microbiome predispose postmenopausal women to recurrent cystitis. This will be explored using comparison of microbiome profiles between those with recurrent UTI compared to age-matched women without recurrent UTI.

Full description

Patients and age-matched control subjects will be recruited from the Urogynecology clinic in Hadassah Mt Scopus and the gynecology clinic, respectively.

After assessment of inclusion and exclusion criteria and patient's consent to participate, a history intake (detailing demographics, medical history, risk factors for rUTI etc.) and gynecological examination will be conducted as part of the usual assessment in the clinic.

Vaginal, urine and fecal samples for microbiome molecular analysis will be collected during clinic visits, given at least one month without antibiotics before samples collection, using agreed protocols and will be kept for future evaluation. Urine will be collected for urinalysis and for a urine culture.

In addition, urine cultures, as well as vaginal, urine and fecal samples for molecular analysis will be collected during an acute UTI episode from the same patients.

Healthy patients (the control group) will be examined only once.

Enrollment

40 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Patients' inclusion criteria:

  • Menopausal status
  • Two or more documented, culture-positive infections in the last six months or ≥3 infections in the last year Patients' exclusion criteria
  • Neurogenic bladder condition
  • Known immunodeficiencies
  • Usage of antibiotics or probiotics within the previous month
  • Known renal calculi or anatomic malformations

Control subjects- Inclusion criteria:

  • Menopausal status
  • Sterile urine cultures, normal urinalysis, and negative sexually-transmitted PCR urine assay

Control subjects- Exclusion criteria:

  • A prior history of UTIs or other urologic abnormalities.

Trial design

40 participants in 2 patient groups

Recurrent Urinary tract infection
Description:
Menopausal women, with two or more documented, culture-positive infections in the last six months or ≥3 infections in the last year
Healthy controls
Description:
Menopausal women, without prior history of UTIs or other urologic abnormalities.

Trial contacts and locations

1

Loading...

Central trial contact

Ahinoam Lev-Sagie, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems